Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN75948817Phase 3Completed
Phase 3, randomised trial in subarachnoid hemorrhage (SAH) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Clinical outcome at six months. Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN75948817.